- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Hong Kong Pharmaceuticals & Biotech Undervalued over 20% based on DCF
UPDATED Oct 20, 2023
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
12 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2269WuXi Biologics (Cayman) | HK$46.10 | -6.1% | 9.4% | HK$196.0b | HK$76.46 | PE44.2x | E23.1% | n/a | ||
| 3692Hansoh Pharmaceutical Group | HK$11.36 | 0.2% | -19.3% | HK$67.3b | HK$15.42 | PE24.5x | E12.4% | 1.2% | ||
| 1093CSPC Pharmaceutical Group | HK$5.58 | -2.1% | -34.6% | HK$66.1b | HK$9.93 | PE10.2x | E3.9% | 5.0% | ||
| 9995RemeGen | HK$37.00 | -13.2% | -20.7% | HK$28.6b | HK$54.92 | PS22.2x | E61.0% | n/a | ||
| 1666Tong Ren Tang Technologies | HK$5.63 | -9.8% | 26.5% | HK$7.2b | HK$7.72 | PE10.7x | E4.0% | 3.0% | ||
| 1477Ocumension Therapeutics | HK$7.25 | -8.0% | -23.7% | HK$5.0b | HK$12.88 | PS22.5x | E46.4% | n/a | ||
| 2348Dawnrays Pharmaceutical (Holdings) | HK$1.05 | -6.3% | 1.9% | HK$1.6b | n/a | PE3.3x | n/a | 8.3% | ||
| 2633Jacobson Pharma | HK$0.63 | -3.1% | -26.7% | HK$1.2b | n/a | PE4.8x | n/a | 8.2% | ||
| 3737Zhongzhi Pharmaceutical Holdings | HK$1.29 | -10.4% | 69.7% | HK$1.1b | n/a | PE6.3x | n/a | 9.2% | ||
| 239Pak Fah Yeow International | HK$1.61 | -1.2% | 56.3% | HK$501.7m | n/a | PE5.7x | n/a | 7.6% | ||
| 455Tianda Pharmaceuticals | HK$0.21 | 0% | 20.3% | HK$458.0m | n/a | PB0.7x | n/a | 1.2% | ||
| 1643Modern Chinese Medicine Group | HK$0.41 | 3.8% | -2.4% | HK$249.0m | n/a | PE3.6x | n/a | 0% |
Page 1 of 1